For advertising queries please email advertising@pharmaphorum.com or for further information visit our Advertise page
For editorial queries please email editorial@pharmaphorum.com or for further information visit our Contribute page
 |
 |
 |
 |
 |
Taiho has suffered a blow to its near-term pipeline after a drug candidate for Duchenne muscular dystrophy (DMD) missed the mark in a phase 3 trial.
Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
Every breakthrough in medicine, every new treatment that changes lives, starts with research.
The importance of biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems.
Deep Dive editor Eloise McLennan debriefs on the key themes, hot topics, and hallway conversations that shaped the HLTH event in Amsterdam.
Developments in the oncology space in 2024 brought hope to both industry and patients.
The World’s Largest, Longest-Standing & Most Comprehensive Antibody-Drug Conjugate Conference
Axtria’s flagship event is almost here! Axtria Ignite 2025 is taking place 4th to 5th June at the Princeton Marriott at Forrestal in New Jersey. This
